Mice congenitally deficient in nicastrin, a nonredundant Notch-activating protease, develop a malignant myeloproliferative disease dominated by cells expressing elevated levels of transcription factors that control myeloid-specific genes such as Ncf1, cFms and Fcrg29. The gene discussed is NCSTN; the disease is myeloproliferative disorder.